IBIO

$0.00

(

0.00%

)
Quote details

stock

iBio, Inc. Common Stock

NASDAQ | IBIO

1.94

USD

(

0.00%

)

At Close (As of Jan 1, 1970)

$54.42M

Market Cap

-

P/E Ratio

-1.21

EPS

$6.89

52 Week High

$0.56

52 Week Low

HEALTHCARE

Sector

IBIO Chart

Recent Chart
Price Action

IBIO Technicals

Tags:

IBIO Earnings

Yearly Income Statement (As of Jun 30, 2025)

Field Value (USD)
Gross Profit $400K
Total Revenue $400K
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$19M
Selling General And Administrative $11M
Research And Development $8.3M
Operating Expenses $19M
Investment Income Net -
Net Interest Income $225K
Interest Income $437K
Interest Expense $212K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.1M
Income Before Tax -$18M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$18M
Comprehensive Income Net Of Tax -
Ebit -$18M
Ebitda -$17M
Net Income -$18M

Revenue & Profitability

IBIO Financials

yearly Income Statement (As of Jun 30, 2025)

Field Value (USD)
Gross Profit $400K
Total Revenue $400K
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$19M
Selling General And Administrative $11M
Research And Development $8.3M
Operating Expenses $19M
Investment Income Net -
Net Interest Income $225K
Interest Income $437K
Interest Expense $212K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.1M
Income Before Tax -$18M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$18M
Comprehensive Income Net Of Tax -
Ebit -$18M
Ebitda -$17M
Net Income -$18M

IBIO Profile

iBio, Inc. Common Stock Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

iBio, Inc. is an innovative biotechnology company headquartered in New York, specializing in plant-based biopharmaceutical production. The company provides contract development and manufacturing services tailored to the production of biologics, including vaccines and therapeutics, thereby positioning itself as a critical partner for organizations both domestically and globally. Leveraging its proprietary technologies, iBio is committed to advancing the efficiency and scalability of biologics manufacturing, effectively addressing the growing demand for sustainable and cost-effective solutions in the dynamic life sciences industry.

LPTX
+368.57%
$2.05
PAVS
+19.13%
$0.04
YCBD
+91.75%
$1.21
OCG
-75.85%
$0.22
NVDA
-3.26%
$175.02
CGC
+51.33%
$1.71
YGMZ
-61.42%
$0.02
WOK
-35.71%
$0.10
PLUG
-1.69%
$2.32
ASST
-6.35%
$0.86
RIVN
+12.11%
$18.42
TSLA
+2.30%
$457.20
INTC
-4.30%
$37.81
ONDS
-1.82%
$8.85
TLRY
+43.90%
$12.13
ATPC
-25.11%
$0.13
AVGO
-12.32%
$356.27
KIND
+9.48%
$2.77
IQ
-4.41%
$1.95
AXDX
-61.36%
$0.03
TNYA
-37.50%
$0.85
FRMI
-33.83%
$10.09
AKAN
+19.53%
$0.94
KAVL
-35.55%
$0.12
ORCL
-4.60%
$189.69
SOFI
+0.77%
$27.28
TE
-8.94%
$5.34
VIVK
-1.75%
$0.07
ADAP
-15.14%
$0.05
ZDGE
+18.51%
$2.88
F
+0.88%
$13.75
PLTD
+2.29%
$6.46
AAL
0.00%
$14.96
HPE
-2.68%
$23.88
KVUE
-0.02%
$17.31
SOND
-23.45%
$0.12
MARA
-2.70%
$11.52
PLTR
-2.11%
$183.57
VALE
-4.43%
$12.70
BAC
+1.11%
$55.17
RMBL
+60.50%
$3.21
RR
-11.85%
$4.12
BMNR
-8.59%
$35.08
LNW
-3.71%
$86.22
WULF
-6.66%
$14.77
ADD
-25.47%
$0.05
BMNU
-18.10%
$8.36
SNAP
-4.38%
$7.30
BITF
-6.80%
$2.74
CLSK
-5.33%
$14.03
DNN
-5.06%
$2.62
APLT
-45.91%
$0.11
ACHR
-2.27%
$8.36
IREN
-8.67%
$40.13
IVP
-12.42%
$0.04
RZLT
+28.57%
$1.80
SRM
+53.27%
$10.30
AMZN
-1.77%
$226.19
PFE
-0.01%
$25.79
BYND
-5.93%
$1.11
IRBT
-14.60%
$4.27
GOOGL
-1.00%
$309.29
QBTS
-6.71%
$26.10
NIO
-2.04%
$5.02
CIFR
-9.69%
$17.05
NFLX
+1.72%
$95.71
ASBP
-5.64%
$0.09
AMD
-4.89%
$210.59
RKLB
-3.05%
$61.59
GRAB
-0.57%
$5.15
SMR
-13.59%
$18.33
BBD
+1.46%
$3.46
CRWV
-8.43%
$80.00
MTSR
-0.35%
$70.50
FI
+2.38%
$68.16
ABEV
+1.80%
$2.54
WBD
+1.33%
$29.88
HOOD
-2.39%
$120.42
JBLU
+1.02%
$4.94
AAPL
-0.15%
$277.59
HL
-2.76%
$18.81
CHR
0.00%
$0.04
APLD
-9.42%
$27.86
CAN
-8.01%
$0.85
SOUN
-2.82%
$11.69
CDE
-1.31%
$17.25
BTG
-1.07%
$4.62
AFMD
-34.94%
$0.18
T
+0.89%
$24.51
AG
-5.37%
$15.90
BTBT
-8.22%
$2.25
DVLT
-4.16%
$1.38
NOK
-1.49%
$6.26
EOSE
-9.73%
$14.84
KPLT
+14.90%
$7.13
TWOH
0.00%
$0.00
GOOG
-1.01%
$310.52
LUV
+1.08%
$41.18
GRYP
-10.38%
$1.38
TSM
-4.16%
$292.14
LPTX
+368.57%
$2.05
PAVS
+19.13%
$0.04
YCBD
+91.75%
$1.21
OCG
-75.85%
$0.22
NVDA
-3.26%
$175.02
CGC
+51.33%
$1.71
YGMZ
-61.42%
$0.02
WOK
-35.71%
$0.10
PLUG
-1.69%
$2.32
ASST
-6.35%
$0.86
RIVN
+12.11%
$18.42
TSLA
+2.30%
$457.20
INTC
-4.30%
$37.81
ONDS
-1.82%
$8.85
TLRY
+43.90%
$12.13
ATPC
-25.11%
$0.13
AVGO
-12.32%
$356.27
KIND
+9.48%
$2.77
IQ
-4.41%
$1.95
AXDX
-61.36%
$0.03
TNYA
-37.50%
$0.85
FRMI
-33.83%
$10.09
AKAN
+19.53%
$0.94
KAVL
-35.55%
$0.12
ORCL
-4.60%
$189.69
SOFI
+0.77%
$27.28
TE
-8.94%
$5.34
VIVK
-1.75%
$0.07
ADAP
-15.14%
$0.05
ZDGE
+18.51%
$2.88
F
+0.88%
$13.75
PLTD
+2.29%
$6.46
AAL
0.00%
$14.96
HPE
-2.68%
$23.88
KVUE
-0.02%
$17.31
SOND
-23.45%
$0.12
MARA
-2.70%
$11.52
PLTR
-2.11%
$183.57
VALE
-4.43%
$12.70
BAC
+1.11%
$55.17
RMBL
+60.50%
$3.21
RR
-11.85%
$4.12
BMNR
-8.59%
$35.08
LNW
-3.71%
$86.22
WULF
-6.66%
$14.77
ADD
-25.47%
$0.05
BMNU
-18.10%
$8.36
SNAP
-4.38%
$7.30
BITF
-6.80%
$2.74
CLSK
-5.33%
$14.03
DNN
-5.06%
$2.62
APLT
-45.91%
$0.11
ACHR
-2.27%
$8.36
IREN
-8.67%
$40.13
IVP
-12.42%
$0.04
RZLT
+28.57%
$1.80
SRM
+53.27%
$10.30
AMZN
-1.77%
$226.19
PFE
-0.01%
$25.79
BYND
-5.93%
$1.11
IRBT
-14.60%
$4.27
GOOGL
-1.00%
$309.29
QBTS
-6.71%
$26.10
NIO
-2.04%
$5.02
CIFR
-9.69%
$17.05
NFLX
+1.72%
$95.71
ASBP
-5.64%
$0.09
AMD
-4.89%
$210.59
RKLB
-3.05%
$61.59
GRAB
-0.57%
$5.15
SMR
-13.59%
$18.33
BBD
+1.46%
$3.46
CRWV
-8.43%
$80.00
MTSR
-0.35%
$70.50
FI
+2.38%
$68.16
ABEV
+1.80%
$2.54
WBD
+1.33%
$29.88
HOOD
-2.39%
$120.42
JBLU
+1.02%
$4.94
AAPL
-0.15%
$277.59
HL
-2.76%
$18.81
CHR
0.00%
$0.04
APLD
-9.42%
$27.86
CAN
-8.01%
$0.85
SOUN
-2.82%
$11.69
CDE
-1.31%
$17.25
BTG
-1.07%
$4.62
AFMD
-34.94%
$0.18
T
+0.89%
$24.51
AG
-5.37%
$15.90
BTBT
-8.22%
$2.25
DVLT
-4.16%
$1.38
NOK
-1.49%
$6.26
EOSE
-9.73%
$14.84
KPLT
+14.90%
$7.13
TWOH
0.00%
$0.00
GOOG
-1.01%
$310.52
LUV
+1.08%
$41.18
GRYP
-10.38%
$1.38
TSM
-4.16%
$292.14

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.